For many companies, universities have become essential innovation partners. However, companies often struggle to establish and run university partnerships effectively.
A pitch competition held in Annapolis last week had an eye toward innovation on the farm – whether the growing was on land or water.
For the first time, the Rural Maryland Council Summit included the AgPitch Competition. Westminster-based MidAtlantic Farm Credit was an organizer of the Dec. 1 event. The pitch competition featured five entrepreneurs.
Even though the federal government avoided a shutdown last week — at least temporarily — continued uncertainty in the nation’s budget process could hurt Maryland’s economy.
Congress agreed Thursday night to a spending bill that will keep the government funded and running through Dec. 22, but the short-term extension may not do much to ease concerns in a state where so many workers and jobs are tied to federal spending.
“The American Angel (pdf),” a new comprehensive national study released yesterday, provides a detailed picture of angel investors–who they are, where they live, and how they make investment decisions.
BioBuzz: What is ATOM and why should people know about it?
Jim: It is a public–private consortium designed to improve the oncology drug discovery process by bringing together the expertise and resources of the FNLCR, the Lawrence Livermore National Laboratory (LLNL), GSK, and the University of California–San Francisco (UCSF).
VLP Therapeutics was established in 2013 with the mission to develop innovative medical treatments which can transform traditional vaccines and targeted antibody therapies to address global unmet medical needs. Its vision is to combat 21st century global public health problems through its revolutionary next generation i-αVLP technology platform. VLP is currently developing vaccines to treat cancer and infectious diseases such as Malaria and Dengue Fever.
British pharmaceutical giant GlaxoSmithKline PLC said it finally has a full team in place at its vaccine hub in Rockville and is ready to take on some of the region’s most well-known biotech competitors with part of its product lineup.
University of Maryland, Baltimore startup Harpoon Medical was acquired by Edwards Lifesciences for $100 million, Edwards announced Wednesday. The deal could rise to $150 million if Harpoon meets pre-specified milestones. Harpoon’s primary product is a device designed to facilitate beating-heart, minimally invasive, echo-guided mitral valve repair. Clinical trials have shown that the product leads to positive safety
TearSolutions, a Charlottesville-based biotechnology startup just received an $8.5 million shot in the arm, courtesy of the VTC Innovation Fund and Pharmstandard International, one of Russia’s largest pharmaceutical companies.
A new innovation space from the University of Maryland, Baltimore is opening inside the historic Lion Brothers building on Hollins Street.
About 6,200 square feet of the 38,000-square-foot building will be dedicated to offices, class/meeting rooms and coworking space geared toward supporting entrepreneurship and technology startups. The new space will be called the GRID, an acronym for Graduate Research Innovation District, and will be housed in the revamped former Lion Brothers Co. clothing and embroidery factory near the university’s BioPark campus.